Category Archives: Cancer Treatments
Children may not experience the same brain tumour side effects and symptoms as adults.
Because their brains and bodies are still growing, they may experience symptoms and side effects that are unique to their age and stage of development.
Children, adolescents and young adults with brain tumors generally experience various side-effects from brain cancer, including Physical Side Effects, Eating and Nutrition Issues, Changes in Physical Appearance, Cognitive and Emotional Side Effects, as well as Long-Term or Late Effects.
Neurocognitive problems are an unfortunate potential side effect of childhood brain tumours. These can vary widely, and can affect intellectual ability, academic achievement, memory and attention.
Potential problems can be assessed by a pediatric neuro-psychologist who can help determine the types of issues that need to be addressed and their treatments.
Symptom Management, Palliative Care, or Supportive Care to relieve side-effects is an important part of cancer care and treatment and should always form part of the overall treatment plan.
Around 70% of cancer survivors report difficulties with memory and concentration after undergoing chemotherapy – this is conversationally referred to as “Chemobrain,” which is described as a mental clouding or fogginess, during and after cancer treatment.
Chemobrain refers to the cognitive impairment that can occur after cancer treatment. It’s not limited to people who undergo chemotherapy (surgery and radiation can also contribute), but it’s more noticeable if one has undergone chemotherapy.
Doctors used to dismiss patients who complained of brain fog after cancer treatment. It’s still unclear exactly how many patients among the 15-million-plus cancer survivors are affected.
Chemotherapy is the use of specific drugs, administered by a paediatric oncologist, to destroy cancer cells by preventing the cancer cells from growing and dividing to make more new cells. Cancer cells generally grow and divide much faster than healthy cells; chemotherapy destroys them more quickly than it destroys most healthy cells.
Chemotherapy drugs are very powerful and they cause damage to many growing cells, including some healthy cells. This damage causes the side effects of chemotherapy, which can include Nausea and Vomiting; Diarrhoea; Constipation; Heartburn or Stomach Ache; Sore Mouth or Throat/Mouth Sores; Change in Taste – Foods Have Less Taste or a Bitter Metallic Taste; Hair Loss; Skin Redness; Dry, Itching Skin; Moist Skin; Rashes; Sun Sensitivity; Swelling, Redness, or Pain at The Needle Site Where Chemotherapy Drugs are Given; Bladder Irritation and Infection; Change in Urine Colour & Strong Urine Odour; Nerve Damage; Stress Fractures; Fever; Flu-Like Symptoms; Infection; Anaemia/Fatigue; Blood Clotting Problems (Bleeding); Swelling/Fluid Retention; and Allergic Reaction.
Cancer can never really be “cured” – one just goes into “remission” because the cancer can come back at any time, and when it does it is generally a far worse strain.
Cancer Survivors live their lives knowing that they have this “time-bomb” inside of them that may go off again at any time, and that there is absolutely nothing that they can do about it – one just lives with the constant fear of recurrence.
New research by Mayo Clinic’s Tim Kottke and his team, which was recently published in the journal Cancer Immunology Research, may hold some hope though.
The new research was a collaborative effort among scientists at the Institute of Cancer Research in London, the Leeds Institute of Cancer and Pathology, and the University of Surrey in Guildford — all of which are in the United Kingdom — and researchers from the Mayo Clinic in Rochester, MN.
Chimeric Antigen Receptor (CAR) T-Cell Therapy is a form of cancer immunotherapy which seeks to sharpen and strengthen the immune system’s inherent cancer-fighting powers.
CAR T-Cell Therapy was approved in August 2017 ~ the first time that the Food and Drug Administration (FDA) approved CAR T-cell therapy for a form of cancer ~ for the treatment of paediatric and young adult patients with B-cell ALL that has relapsed or hasn’t responded to previous treatments.
Acute Lymphoblastic Leukaemia (ALL) is a type of leukaemia in which a group of white blood cells, called lymphocytes, are affected. Leukaemia is the most common form of cancer in children, and about 80% of children with leukaemia have Acute Lymphoblastic Leukaemia.
CAR T-Cell Therapy involves treating patients with modified versions of their own immune system T cells – white blood cells that help protect the body from disease.
Lewis Silverman, MD, Clinical Director of the Hematologic Malignancy Center at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, said:
“It’s a very exciting development in our ability to treat childhood ALL. It offers hope to those that we haven’t been able to treat with conventional therapy. This is a hugely exciting time in childhood leukaemia research”
There’s something magical about making a wish while blowing dandelion petals through the air. Just one glance at a dandelion brings back childhood memories. And while some consider them pesky weeds, dandelion offers a treasure trove of healing benefits.
Dandelion greens are used in so many health applications today. Whether steamed, sautéed, used in soup, or boiled with water and brown sugar for tea, the greens of these weeds are considered an herbal medicine.
The extract (from dandelion root) is purported to work by inducing apoptosis in the cancer cells. To put this another way, this process forces the cancer cells to commit suicide without damaging the healthy cells in any way.
Dandelion Root is frequently used by herbalists to treat liver, kidney, and gallbladder problems. Dandelion Root has been used in China for certain kinds of cancers for centuries. Dandelion is a source of a variety of nutrients and the leaves and root contain Vitamins (A,C, K and B-vitamins) as well as minerals (including magnesium, zinc, potassium, iron, calcium and choline).
There are hundreds of ways to heal cancer and enzyme therapy is seen to be a very effective treatment.
The idea of healing cancer with enzymes was first discovered by Dr John Beard, an embryologist who spent 20 years researching cancer.
He found that pancreatic enzymes were not present in the blood of cancer patients. Although his first article was published in 1902, his theory about cancer still holds up to rigorous scientific scrutiny.
Dr John Beard proposed in 1906 that pancreatic proteolytic digestive enzymes represent the body’s main defence against cancer, and that enzyme therapy would be useful as a treatment for all types of cancer.
During the first two decades of the twentieth century, Dr Beard’s thesis attracted some attention in academic circles, and several case reports in the medical literature documented tumour regression and even remission in terminal cancer patients treated with proteolytic enzymes.
In 1911, Dr Beard published a monograph entitled The Enzyme Therapy of Cancer and Its Scientific Basis, which summarised his therapy and the supporting evidence.
After Dr Beard’s death in 1923, the enzyme therapy was largely forgotten. Periodically, other practitioners have rediscovered Dr Beard’s work, and used pancreatic proteolytic enzymes as an alternative cancer treatment.
Hippocrates is credited with saying “Let medicine be thy food and let food be thy medicine”.
Dr. Johanna Budwig, however, is known for implementing this belief and making it a reality in her medical practices.
Dr. Johanna Budwig had a doctorate in physics and PhD in natural science, and was also a chemist and qualified pharmacologist. In the 1950’s, she was the chief expert consultant for drugs and fats at the Bundesanstalt fur Fettforschung, or Federal Institute for Fats Research, in Germany.
Budwig began analysing the blood of thousands of cancer patients, and found two striking common themes throughout the samples she took. The first was that almost all very ill cancer patients were extremely deficient in phosphatides and lipoproteins (two types of fat molecules produced in the body that are essential for NORMAL cell division).
She also noticed that whereas a healthy person’s blood would contain red, oxygen-carrying haemoglobin, in its place the cancer patients’ blood contained a “greenish-yellow substance.”
The use of magnets as a medical device goes back centuries, maybe even to the ancient Aztecs of Central America.
In the 14th century, Paracelsus, a physician and alchemist, claimed that steel magnets could attract diseases out of the body, and help draw them to the surface where they could be removed.
The Ancient Greeks discovered lodestone which is considered by many to be the very first natural magnet. Hippocrates, the father of modern medicine, discussed the use of magnets in his healing protocols.
An American who became interested in magnetic healing, Daniel David Palmer, opened Palmer’s School of Magnetic Cure in Iowa in the 1890s. His ideas developed into the system of hands-on therapy known today as chiropractic.
While Magnets are used in complex medical imaging procedures – such as Magnetic Resonance Imaging (MRI), which uses magnetic fields to formulate 3-D images of the brain and electroencephalographs (EEG), which look at the electrical activity of the brain – to better understand the body, and magnets are used as a healing therapy throughout many areas of Europe and Asia, the therapy has not been accepted by the traditional medical community in many countries.
Up until now, drug companies have been free to decide whether to pursue treatments for paediatric cancers as part of their work on adult cancers or not, and this has led to a minimal amount of new drugs specifically for paediatric cancers being developed.
An estimated 2,000 children die of cancer annually, and the overall incidence of childhood cancer has been slowly increasing since 1975 – there has been a 13% rise in Childhood Cancer in the past 20 years alone.
Despite significant advances against certain pediatric cancers, including Acute Lymphoblastic Leukemia, there are still some types of cancer for which there are few or no effective treatments.
The truth is that new drug development in pediatric cancer is extremely slow, often lagging way behind adult treatments, and few compounds are designed specifically for children.
The sad truth is that Childhood cancers make up less than 1% of all cancers diagnosed each year, and that is is not much of a market for drug makers, who rack up an estimated $1.4 billion in out-of-pocket costs while bringing a novel drug to market.